Hycodan Tablets (2014-03-03) Mar 3, 2014 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength KNPP Recalling Firm Bristol-Myers Squibb Canada 2344 Alfred-Nobel, Suite 300 Saint-Laurent H4S 0A4 Quebec CANADA Marketing Authorization Holder Bristol-Myers Squibb Canada 2344 Alfred-Nobel, Suite 300 Saint-Laurent H4S 0A4 Quebec CANADA A. Hycodan Tablets Tablets DIN 01916599 5 mg
Recalled products
Hycodan Tablets
Lot
KNPP did not meet dissolution specifications at the 12-month stability test point, and there is a risk that lot
FSTN may not meet dissolution specifications at the end of shelf-life.
Wholesalers across Canada